{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:00:06Z","timestamp":1792519206736,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-68992-6","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T07:02:35Z","timestamp":1723100555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Paeonol alleviates ulcerative colitis by modulating PPAR-\u03b3 and nuclear factor-\u03baB activation"],"prefix":"10.1038","volume":"14","author":[{"given":"Shuyu","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjie","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"68992_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cgh.2019.07.005","volume":"18","author":"C Le Berre","year":"2020","unstructured":"Le Berre, C., Ananthakrishnan, A. N., Danese, S., Singh, S. & Peyrin-Biroulet, L. Ulcerative colitis and Crohn\u2019s disease have similar burden and goals for treatment. Clin. Gastroenterol. Hepatol. 18, 14\u201323. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.005 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"68992_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi, T. et al. Ulcerative colitis. Nat. Rev. Dis. Primers 6, 74. https:\/\/doi.org\/10.1038\/s41572-020-0205-x (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"68992_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","volume":"395","author":"O Ol\u00e9n","year":"2020","unstructured":"Ol\u00e9n, O. et al. Colorectal cancer in ulcerative colitis: A Scandinavian population-based cohort study. Lancet 395, 123\u2013131. https:\/\/doi.org\/10.1016\/S0140-6736(19)32545-0 (2020).","journal-title":"Lancet"},{"key":"68992_CR4","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/ibd\/izz149","volume":"25","author":"D Yao","year":"2019","unstructured":"Yao, D., Dong, M., Dai, C. & Wu, S. Inflammation and inflammatory cytokine contribute to the initiation and development of ulcerative colitis and its associated cancer. Inflamm. Bowel Dis. 25, 1595\u20131602. https:\/\/doi.org\/10.1093\/ibd\/izz149 (2019).","journal-title":"Inflamm. Bowel Dis."},{"key":"68992_CR5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.04.074","author":"V Mitsialis","year":"2020","unstructured":"Mitsialis, V. et al. Single-cell analyses of colon and blood reveal distinct immune cell signatures of ulcerative colitis and Crohn\u2019s disease. Gastroenterology https:\/\/doi.org\/10.1053\/j.gastro.2020.04.074 (2020).","journal-title":"Gastroenterology"},{"key":"68992_CR6","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1053\/j.gastro.2016.11.019","volume":"152","author":"T Grabinger","year":"2017","unstructured":"Grabinger, T. et al. Inhibitor of apoptosis protein-1 regulates tumor necrosis factor-mediated destruction of intestinal epithelial cells. Gastroenterology 152, 867\u2013879. https:\/\/doi.org\/10.1053\/j.gastro.2016.11.019 (2017).","journal-title":"Gastroenterology"},{"key":"68992_CR7","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.2174\/1381612827666210218141847","volume":"27","author":"S Papoutsopoulou","year":"2021","unstructured":"Papoutsopoulou, S. & Campbell, B. J. Epigenetic modifications of the nuclear factor kappa B signalling pathway and its impact on inflammatory bowel disease. Curr. Pharm Des. 27, 3702\u20133713. https:\/\/doi.org\/10.2174\/1381612827666210218141847 (2021).","journal-title":"Curr. Pharm Des."},{"key":"68992_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243010","volume":"16","author":"E Nissim-Eliraz","year":"2021","unstructured":"Nissim-Eliraz, E., Nir, E., Marsiano, N., Yagel, S. & Shpigel, N. Y. NF-kappa-B activation unveils the presence of inflammatory hotspots in human gut xenografts. PLoS One 16, e0243010. https:\/\/doi.org\/10.1371\/journal.pone.0243010 (2021).","journal-title":"PLoS One"},{"key":"68992_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/bs.ircmb.2017.07.007","volume":"335","author":"JP Mitchell","year":"2018","unstructured":"Mitchell, J. P. & Carmody, R. J. NF-\u03baB and the transcriptional control of inflammation. Int. Rev. Cell Mol. Biol. 335, 41\u201384. https:\/\/doi.org\/10.1016\/bs.ircmb.2017.07.007 (2018).","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"68992_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","volume":"18","author":"M Karin","year":"2000","unstructured":"Karin, M. & Ben-Neriah, Y. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Ann. Rev. Immunol. 18, 621\u2013663 (2000).","journal-title":"Ann. Rev. Immunol."},{"key":"68992_CR11","doi-asserted-by":"publisher","first-page":"5498115","DOI":"10.1155\/2022\/5498115","volume":"2022","author":"B Venkataraman","year":"2022","unstructured":"Venkataraman, B. et al. \u03b1-Bisabolol mitigates colon inflammation by stimulating colon PPAR-\u03b3 transcription factor: In vivo and in vitro study. PPAR Res. 2022, 5498115. https:\/\/doi.org\/10.1155\/2022\/5498115 (2022).","journal-title":"PPAR Res."},{"key":"68992_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.lfs.2018.01.016","volume":"196","author":"P Shen","year":"2018","unstructured":"Shen, P. et al. Magnolol treatment attenuates dextran sulphate sodium-induced murine experimental colitis by regulating inflammation and mucosal damage. Life Sci. 196, 69\u201376. https:\/\/doi.org\/10.1016\/j.lfs.2018.01.016 (2018).","journal-title":"Life Sci."},{"key":"68992_CR13","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0016-5085(03)00271-3","volume":"124","author":"L Dubuquoy","year":"2003","unstructured":"Dubuquoy, L. et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 124, 1265\u20131276 (2003).","journal-title":"Gastroenterology"},{"key":"68992_CR14","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/ajg.2009.749","volume":"105","author":"G Pedersen","year":"2010","unstructured":"Pedersen, G. & Brynskov, J. Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-gamma activity. Am. J. Gastroenterol. 105, 1595\u20131603. https:\/\/doi.org\/10.1038\/ajg.2009.749 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"68992_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.114919","volume":"391","author":"E-SA Arafa","year":"2020","unstructured":"Arafa, E.-S.A., Mohamed, W. R., Zaher, D. M. & Omar, H. A. Gliclazide attenuates acetic acid-induced colitis via the modulation of PPAR\u03b3, NF-\u03baB and MAPK signaling pathways. Toxicol. Appl. Pharmacol. 391, 114919. https:\/\/doi.org\/10.1016\/j.taap.2020.114919 (2020).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"68992_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ejphar.2007.01.047","volume":"562","author":"M S\u00e1nchez-Hidalgo","year":"2007","unstructured":"S\u00e1nchez-Hidalgo, M., Mart\u00edn, A. R., Villegas, I. & de la Lastra, C. A. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats. Eur. J. Pharmacol. 562, 247\u2013258 (2007).","journal-title":"Eur. J. Pharmacol."},{"key":"68992_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.03227-20","author":"SA Cevallos","year":"2021","unstructured":"Cevallos, S. A. et al. 5-Aminosalicylic acid ameliorates colitis and checks dysbiotic Escherichia coli expansion by activating PPAR-\u03b3 signaling in the intestinal epithelium. mBio https:\/\/doi.org\/10.1128\/mBio.03227-20 (2021).","journal-title":"mBio"},{"key":"68992_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115652","volume":"299","author":"S Huang","year":"2022","unstructured":"Huang, S. et al. Dahuang Mudan decoction repairs intestinal barrier in chronic colitic mice by regulating the function of ILC3. J. Ethnopharmacol. 299, 115652. https:\/\/doi.org\/10.1016\/j.jep.2022.115652 (2022).","journal-title":"J. Ethnopharmacol."},{"key":"68992_CR19","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.19540\/j.cnki.cjcmm.20210508.301","volume":"46","author":"J-Y Yang","year":"2021","unstructured":"Yang, J.-Y. et al. Pharmacological effects of Huangqin Decoction prepared from roots of multi-originated peony on ulcerative colitis in mice: A comparative study. Zhongguo Zhong Yao Za Zhi 46, 6395\u20136402. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20210508.301 (2021).","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"68992_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jep.2014.12.039","volume":"162","author":"P Chen","year":"2015","unstructured":"Chen, P. et al. Anti-inflammatory effects of Huangqin tang extract in mice on ulcerative colitis. J. Ethnopharmacol. 162, 207\u2013214. https:\/\/doi.org\/10.1016\/j.jep.2014.12.039 (2015).","journal-title":"J. Ethnopharmacol."},{"key":"68992_CR21","doi-asserted-by":"publisher","first-page":"7574","DOI":"10.12659\/MSM.917695","volume":"25","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y., Li, X., Xu, X. & Yang, N. Mechanisms of Paeonia lactiflora in treatment of ulcerative colitis: A network pharmacological study. Med. Sci. Monit. 25, 7574\u20137580. https:\/\/doi.org\/10.12659\/MSM.917695 (2019).","journal-title":"Med. Sci. Monit."},{"key":"68992_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.696158","volume":"12","author":"K-C Wu","year":"2021","unstructured":"Wu, K.-C. et al. Evaluations and mechanistic interrogation of natural products isolated from Paeonia suffruticosa for the treatment of inflammatory bowel disease. Front. Pharmacol. 12, 696158. https:\/\/doi.org\/10.3389\/fphar.2021.696158 (2021).","journal-title":"Front. Pharmacol."},{"key":"68992_CR23","doi-asserted-by":"publisher","first-page":"17238","DOI":"10.1038\/s41598-020-74201-x","volume":"10","author":"T-F Chen","year":"2020","unstructured":"Chen, T.-F. et al. A systematic identification of anti-inflammatory active components derived from Mu Dan Pi and their applications in inflammatory bowel disease. Sci. Rep. 10, 17238. https:\/\/doi.org\/10.1038\/s41598-020-74201-x (2020).","journal-title":"Sci. Rep."},{"key":"68992_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2021.114529","volume":"209","author":"K Wang","year":"2022","unstructured":"Wang, K., Guo, J., Chang, X. & Gui, S. Painong-San extract alleviates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota, restoring intestinal barrier function and attenuating TLR4\/NF-\u03baB signaling cascades. J. Pharm. Biomed. Anal. 209, 114529. https:\/\/doi.org\/10.1016\/j.jpba.2021.114529 (2022).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"68992_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.intimp.2019.04.033","volume":"72","author":"L Zhang","year":"2019","unstructured":"Zhang, L., Li, D.-C. & Liu, L.-F. Paeonol: Pharmacological effects and mechanisms of action. Int. Immunopharmacol. 72, 413\u2013421. https:\/\/doi.org\/10.1016\/j.intimp.2019.04.033 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"68992_CR26","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1002\/ptr.6472","volume":"33","author":"G Chen","year":"2019","unstructured":"Chen, G. et al. Paeonol ameliorates monosodium urate-induced arthritis in rats through inhibiting nuclear factor-\u03baB-mediated proinflammatory cytokine production. Phytother. Res. 33, 2971\u20132978. https:\/\/doi.org\/10.1002\/ptr.6472 (2019).","journal-title":"Phytother. Res."},{"key":"68992_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1691\/ph.2019.8860","volume":"74","author":"F Wang","year":"2019","unstructured":"Wang, F. et al. Paeonol ameliorates lipopolysaccharides-induced acute lung injury by regulating TLR4\/MyD88\/ NF-\u03baB signaling pathway. Pharmazie 74, 101\u2013106. https:\/\/doi.org\/10.1691\/ph.2019.8860 (2019).","journal-title":"Pharmazie"},{"key":"68992_CR28","doi-asserted-by":"publisher","first-page":"8641026","DOI":"10.1155\/2020\/8641026","volume":"2020","author":"AY Al-Taher","year":"2020","unstructured":"Al-Taher, A. Y., Morsy, M. A., Rifaai, R. A., Zenhom, N. M. & Abdel-Gaber, S. A. Paeonol attenuates methotrexate-induced cardiac toxicity in rats by inhibiting oxidative stress and suppressing TLR4-induced NF-\u03baB inflammatory pathway. Mediators Inflamm. 2020, 8641026. https:\/\/doi.org\/10.1155\/2020\/8641026 (2020).","journal-title":"Mediators Inflamm."},{"key":"68992_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-017-0385-5","author":"K-F Zhai","year":"2017","unstructured":"Zhai, K.-F. et al. Protective effects of paeonol on inflammatory response in IL-1\u03b2-induced human fibroblast-like synoviocytes and rheumatoid arthritis progression via modulating NF-\u03baB pathway. Inflammopharmacology https:\/\/doi.org\/10.1007\/s10787-017-0385-5 (2017).","journal-title":"Inflammopharmacology"},{"key":"68992_CR30","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1007\/s10753-017-0611-8","volume":"40","author":"Y Lou","year":"2017","unstructured":"Lou, Y. et al. Paeonol Inhibits IL-1\u03b2-Induced Inflammation via PI3K\/Akt\/NF-\u03baB Pathways: In vivo and vitro studies. Inflammation 40, 1698\u20131706. https:\/\/doi.org\/10.1007\/s10753-017-0611-8 (2017).","journal-title":"Inflammation"},{"key":"68992_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.taap.2006.07.002","volume":"217","author":"K Ishiguro","year":"2006","unstructured":"Ishiguro, K. et al. Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivation. Toxicol. Appl. Pharmacol. 217, 35\u201342 (2006).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"68992_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/mmy\/myaa053","volume":"59","author":"Y Ge","year":"2021","unstructured":"Ge, Y. et al. Paeonol alleviates dextran sodium sulfate induced colitis involving Candida albicans-associated dysbiosis. Med. Mycol. 59, 335\u2013344. https:\/\/doi.org\/10.1093\/mmy\/myaa053 (2021).","journal-title":"Med. Mycol."},{"key":"68992_CR33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s10753-015-0265-3","volume":"39","author":"X Jin","year":"2016","unstructured":"Jin, X. et al. Anti-inflammatory and anti-oxidative activities of paeonol and its metabolites through blocking MAPK\/ERK\/p38 signaling pathway. Inflammation 39, 434\u2013446. https:\/\/doi.org\/10.1007\/s10753-015-0265-3 (2016).","journal-title":"Inflammation"},{"key":"68992_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12868-022-00698-9","volume":"23","author":"H Zhao","year":"2022","unstructured":"Zhao, H., Wang, X., Liu, S. & Zhang, Q. Paeonol regulates NLRP3 inflammasomes and pyroptosis to alleviate spinal cord injury of rat. BMC Neurosci. 23, 16. https:\/\/doi.org\/10.1186\/s12868-022-00698-9 (2022).","journal-title":"BMC Neurosci."},{"key":"68992_CR35","doi-asserted-by":"publisher","first-page":"4535194","DOI":"10.1155\/2017\/4535194","volume":"2017","author":"T Tian","year":"2017","unstructured":"Tian, T., Wang, Z. & Zhang, J. Pathomechanisms of oxidative stress in inflammatory bowel disease and potential antioxidant therapies. Oxid. Med. Cell Longev. 2017, 4535194. https:\/\/doi.org\/10.1155\/2017\/4535194 (2017).","journal-title":"Oxid. Med. Cell Longev."},{"key":"68992_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2022.213126","volume":"142","author":"M Yan","year":"2022","unstructured":"Yan, M. et al. ROS responsive polydopamine nanoparticles to relieve oxidative stress and inflammation for ameliorating acute inflammatory bowel. Biomater. Adv. 142, 213126. https:\/\/doi.org\/10.1016\/j.bioadv.2022.213126 (2022).","journal-title":"Biomater. Adv."},{"key":"68992_CR37","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3389\/fphar.2017.00981","volume":"8","author":"K Wang","year":"2017","unstructured":"Wang, K. et al. Bergenin, acting as an agonist of PPAR\u03b3, ameliorates experimental colitis in mice through improving expression of SIRT1, and therefore inhibiting NF-\u03baB-mediated macrophage activation. Front. Pharmacol. 8, 981. https:\/\/doi.org\/10.3389\/fphar.2017.00981 (2017).","journal-title":"Front. Pharmacol."},{"key":"68992_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.intimp.2016.11.010","volume":"42","author":"S-Y Zong","year":"2017","unstructured":"Zong, S.-Y., Pu, Y.-Q., Xu, B.-L., Zhang, T. & Wang, B. Study on the physicochemical properties and anti-inflammatory effects of paeonol in rats with TNBS-induced ulcerative colitis. Int. Immunopharmacol. 42, 32\u201338. https:\/\/doi.org\/10.1016\/j.intimp.2016.11.010 (2017).","journal-title":"Int. Immunopharmacol."},{"key":"68992_CR39","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","volume":"129","author":"CN Bernstein","year":"2005","unstructured":"Bernstein, C. N., Wajda, A. & Blanchard, J. F. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129, 827\u2013836 (2005).","journal-title":"Gastroenterology"},{"key":"68992_CR40","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1053\/j.gastro.2022.01.023","volume":"162","author":"N Krugliak Cleveland","year":"2022","unstructured":"Krugliak Cleveland, N., Torres, J. & Rubin, D. T. What does disease progression look like in ulcerative colitis, and how might it be prevented?. Gastroenterology 162, 1396\u20131408. https:\/\/doi.org\/10.1053\/j.gastro.2022.01.023 (2022).","journal-title":"Gastroenterology"},{"key":"68992_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/ibd.20753","volume":"15","author":"P Alex","year":"2009","unstructured":"Alex, P. et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm. Bowel Dis. 15, 341\u2013352. https:\/\/doi.org\/10.1002\/ibd.20753 (2009).","journal-title":"Inflamm. Bowel Dis."},{"key":"68992_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.103017","volume":"21","author":"H Nakase","year":"2022","unstructured":"Nakase, H., Sato, N., Mizuno, N. & Ikawa, Y. The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmun. Rev. 21, 103017. https:\/\/doi.org\/10.1016\/j.autrev.2021.103017 (2022).","journal-title":"Autoimmun. Rev."},{"key":"68992_CR43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.molimm.2020.03.001","volume":"121","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. IL-10 enhances T cell survival and is associated with faster relapse in patients with inactive ulcerative colitis. Mol. Immunol. 121, 92\u201398. https:\/\/doi.org\/10.1016\/j.molimm.2020.03.001 (2020).","journal-title":"Mol. Immunol."},{"key":"68992_CR44","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s10753-020-01400-z","volume":"44","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Long non-coding RNA MEG3 alleviated ulcerative colitis through upregulating miR-98-5p-sponged IL-10. Inflammation 44, 1049\u20131059. https:\/\/doi.org\/10.1007\/s10753-020-01400-z (2021).","journal-title":"Inflammation"},{"key":"68992_CR45","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cyto.2007.07.191","volume":"39","author":"PW Thompson","year":"2007","unstructured":"Thompson, P. W., Bayliffe, A. I., Warren, A. P. & Lamb, J. R. Interleukin-10 is upregulated by nanomolar rosiglitazone treatment of mature dendritic cells and human CD4+ T cells. Cytokine 39, 184\u2013191 (2007).","journal-title":"Cytokine"},{"key":"68992_CR46","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12974-024-03142-3","volume":"21","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Microglial Pdcd4 deficiency mitigates neuroinflammation-associated depression via facilitating Daxx mediated PPAR\u03b3\/IL-10 signaling. J. Neuroinflamm. 21, 143. https:\/\/doi.org\/10.1186\/s12974-024-03142-3 (2024).","journal-title":"J. Neuroinflamm."},{"key":"68992_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12951-022-01314-y","volume":"20","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Exosomes derived from reparative M2-like macrophages prevent bone loss in murine periodontitis models via IL-10 mRNA. J. Nanobiotechnol. 20, 110. https:\/\/doi.org\/10.1186\/s12951-022-01314-y (2022).","journal-title":"J. Nanobiotechnol."},{"key":"68992_CR48","doi-asserted-by":"publisher","first-page":"1139204","DOI":"10.3389\/fimmu.2023.1139204","volume":"14","author":"\u00c9 Garabuczi","year":"2023","unstructured":"Garabuczi, \u00c9. et al. Nur77 and PPAR\u03b3 regulate transcription and polarization in distinct subsets of M2-like reparative macrophages during regenerative inflammation. Front. Immunol. 14, 1139204. https:\/\/doi.org\/10.3389\/fimmu.2023.1139204 (2023).","journal-title":"Front. Immunol."},{"key":"68992_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.765482","volume":"12","author":"X Shi","year":"2021","unstructured":"Shi, X. et al. Paeonol attenuated vascular fibrosis through regulating Treg\/Th17 balance in a gut microbiota-dependent manner. Front. Pharmacol. 12, 765482. https:\/\/doi.org\/10.3389\/fphar.2021.765482 (2021).","journal-title":"Front. Pharmacol."},{"key":"68992_CR50","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4196\/kjpp.2023.27.5.437","volume":"27","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. Paeonol accelerates skin wound healing by regulating macrophage polarization and inflammation in diabetic rats. Korean J. Physiol. Pharmacol. 27, 437\u2013448. https:\/\/doi.org\/10.4196\/kjpp.2023.27.5.437 (2023).","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"68992_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/651890","volume":"2014","author":"M-H Liu","year":"2014","unstructured":"Liu, M.-H. et al. Paeonol attenuates cigarette smoke-induced lung inflammation by inhibiting ROS-sensitive inflammatory signaling. Mediators Inflamm. 2014, 651890. https:\/\/doi.org\/10.1155\/2014\/651890 (2014).","journal-title":"Mediators Inflamm."},{"key":"68992_CR52","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","volume":"12","author":"RN Dubois","year":"1998","unstructured":"Dubois, R. N. et al. Cyclooxygenase in biology and disease. FASEB J. 12, 1063\u20131073 (1998).","journal-title":"FASEB J."},{"key":"68992_CR53","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s10787-007-1603-3","volume":"15","author":"SP Dudhgaonkar","year":"2007","unstructured":"Dudhgaonkar, S. P., Tandan, S. K., Kumar, D., Raviprakash, V. & Kataria, M. Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats. Inflammopharmacology 15, 188\u2013195 (2007).","journal-title":"Inflammopharmacology"},{"key":"68992_CR54","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1172\/JCI6899","volume":"105","author":"O Morteau","year":"2000","unstructured":"Morteau, O. et al. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J. Clin. Invest. 105, 469\u2013478 (2000).","journal-title":"J. Clin. Invest."},{"key":"68992_CR55","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/onc.2009.421","volume":"29","author":"D Wang","year":"2010","unstructured":"Wang, D. & Dubois, R. N. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 29, 781\u2013788. https:\/\/doi.org\/10.1038\/onc.2009.421 (2010).","journal-title":"Oncogene"},{"key":"68992_CR56","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1053\/j.gastro.2019.07.058","volume":"157","author":"W-T Kuo","year":"2019","unstructured":"Kuo, W.-T. et al. Inflammation-induced occludin downregulation limits epithelial apoptosis by suppressing caspase-3 expression. Gastroenterology 157, 1323\u20131337. https:\/\/doi.org\/10.1053\/j.gastro.2019.07.058 (2019).","journal-title":"Gastroenterology"},{"key":"68992_CR57","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1111\/bph.13428","volume":"174","author":"G Aviello","year":"2017","unstructured":"Aviello, G. & Knaus, U. G. ROS in gastrointestinal inflammation: Rescue or sabotage?. Br. J. Pharmacol. 174, 1704\u20131718. https:\/\/doi.org\/10.1111\/bph.13428 (2017).","journal-title":"Br. J. Pharmacol."},{"key":"68992_CR58","doi-asserted-by":"publisher","first-page":"9875298","DOI":"10.1155\/2016\/9875298","volume":"2016","author":"Z Wang","year":"2016","unstructured":"Wang, Z. et al. Oxidative stress and carbonyl lesions in ulcerative colitis and associated colorectal cancer. Oxid. Med. Cell. Longev. 2016, 9875298. https:\/\/doi.org\/10.1155\/2016\/9875298 (2016).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"68992_CR59","doi-asserted-by":"publisher","first-page":"1103617","DOI":"10.3389\/fimmu.2023.1103617","volume":"14","author":"M Zhang","year":"2023","unstructured":"Zhang, M., Li, X., Zhang, Q., Yang, J. & Liu, G. Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer. Front. Immunol. 14, 1103617. https:\/\/doi.org\/10.3389\/fimmu.2023.1103617 (2023).","journal-title":"Front. Immunol."},{"key":"68992_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.999179","volume":"13","author":"Z Yang","year":"2022","unstructured":"Yang, Z. et al. A potential therapeutic target in traditional Chinese medicine for ulcerative colitis: Macrophage polarization. Front. Pharmacol. 13, 999179. https:\/\/doi.org\/10.3389\/fphar.2022.999179 (2022).","journal-title":"Front. Pharmacol."},{"key":"68992_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.625423","volume":"9","author":"X Han","year":"2021","unstructured":"Han, X., Ding, S., Jiang, H. & Liu, G. Roles of macrophages in the development and treatment of gut inflammation. Front. Cell Dev. Biol. 9, 625423. https:\/\/doi.org\/10.3389\/fcell.2021.625423 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"68992_CR62","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/ibd\/izaa273","volume":"27","author":"J Fang","year":"2021","unstructured":"Fang, J., Wang, H., Xue, Z., Cheng, Y. & Zhang, X. PPAR\u03b3: The central mucus barrier coordinator in ulcerative colitis. Inflamm. Bowel Dis. 27, 732\u2013741. https:\/\/doi.org\/10.1093\/ibd\/izaa273 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"68992_CR63","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2174\/13894501113149990162","volume":"14","author":"B Bertin","year":"2013","unstructured":"Bertin, B., Dubuquoy, L., Colombel, J.-F. & Desreumaux, P. PPAR-gamma in ulcerative colitis: A novel target for intervention. Curr. Drug. Targets 14, 1501\u20131507 (2013).","journal-title":"Curr. Drug. Targets"},{"key":"68992_CR64","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1172\/JCI7145","volume":"104","author":"CG Su","year":"1999","unstructured":"Su, C. G. et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J. Clin. Invest. 104, 383\u2013389 (1999).","journal-title":"J. Clin. Invest."},{"key":"68992_CR65","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1084\/jem.193.7.827","volume":"193","author":"P Desreumaux","year":"2001","unstructured":"Desreumaux, P. et al. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)\/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J. Exp. Med. 193, 827\u2013838 (2001).","journal-title":"J. Exp. Med."},{"key":"68992_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.729414","volume":"12","author":"J Dong","year":"2021","unstructured":"Dong, J. et al. Naringin exerts therapeutic effects on mice colitis: A study based on transcriptomics combined with functional experiments. Front. Pharmacol. 12, 729414. https:\/\/doi.org\/10.3389\/fphar.2021.729414 (2021).","journal-title":"Front. Pharmacol."},{"key":"68992_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109058","volume":"111","author":"N Wang","year":"2022","unstructured":"Wang, N. et al. Honokiol alleviates ulcerative colitis by targeting PPAR-\u03b3-TLR4-NF-\u03baB signaling and suppressing gasdermin-D-mediated pyroptosis in vivo and in vitro. Int. Immunopharmacol. 111, 109058. https:\/\/doi.org\/10.1016\/j.intimp.2022.109058 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"68992_CR68","doi-asserted-by":"publisher","first-page":"15240","DOI":"10.1021\/acs.jafc.1c06292","volume":"69","author":"C Cheng","year":"2021","unstructured":"Cheng, C. et al. Hyperoside ameliorates DSS-induced colitis through MKRN1-mediated regulation of PPAR\u03b3 signaling and Th17\/Treg balance. J. Agric. Food Chem. 69, 15240\u201315251. https:\/\/doi.org\/10.1021\/acs.jafc.1c06292 (2021).","journal-title":"J. Agric. Food Chem."},{"key":"68992_CR69","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cmet.2007.06.010","volume":"6","author":"MA Bouhlel","year":"2007","unstructured":"Bouhlel, M. A. et al. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 6, 137\u2013143 (2007).","journal-title":"Cell Metab."},{"key":"68992_CR70","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.intimp.2015.03.005","volume":"26","author":"O Zhang","year":"2015","unstructured":"Zhang, O. & Zhang, J. Atorvastatin promotes human monocyte differentiation toward alternative M2 macrophages through p38 mitogen-activated protein kinase-dependent peroxisome proliferator-activated receptor \u03b3 activation. Int. Immunopharmacol. 26, 58\u201364. https:\/\/doi.org\/10.1016\/j.intimp.2015.03.005 (2015).","journal-title":"Int. Immunopharmacol."},{"key":"68992_CR71","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/wsbm.1331","volume":"8","author":"S Mitchell","year":"2016","unstructured":"Mitchell, S., Vargas, J. & Hoffmann, A. Signaling via the NF\u03baB system. Wiley Interdiscip Rev. Syst. Biol. Med. 8, 227\u2013241. https:\/\/doi.org\/10.1002\/wsbm.1331 (2016).","journal-title":"Wiley Interdiscip Rev. Syst. Biol. Med."},{"key":"68992_CR72","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jcmgh.2019.10.002","volume":"9","author":"J Wong","year":"2020","unstructured":"Wong, J. et al. RIPK1 mediates TNF-induced intestinal crypt apoptosis during chronic NF-\u03baB activation. Cell Mol. Gastroenterol. Hepatol. 9, 295\u2013312. https:\/\/doi.org\/10.1016\/j.jcmgh.2019.10.002 (2020).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"68992_CR73","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1142\/S0192415X19500800","volume":"47","author":"H-J Lee","year":"2019","unstructured":"Lee, H.-J. et al. Anti-inflammatory effects of Canavalia gladiata in macrophage cells and DSS-induced colitis mouse model. Am. J. Chin. Med. 47, 1571\u20131588. https:\/\/doi.org\/10.1142\/S0192415X19500800 (2019).","journal-title":"Am. J. Chin. Med."},{"key":"68992_CR74","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1021\/bi0159581","volume":"41","author":"LM Leesnitzer","year":"2002","unstructured":"Leesnitzer, L. M. et al. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41, 6640\u20136650 (2002).","journal-title":"Biochemistry"},{"key":"68992_CR75","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/sj.bjp.0705973","volume":"143","author":"JM Seargent","year":"2004","unstructured":"Seargent, J. M., Yates, E. A. & Gill, J. H. GW9662, a potent antagonist of PPARgamma, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARgamma agonist rosiglitazone, independently of PPARgamma activation. Br. J. Pharmacol. 143, 933\u2013937 (2004).","journal-title":"Br. J. Pharmacol."},{"key":"68992_CR76","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.brainres.2008.09.074","volume":"1244","author":"J-H Yi","year":"2008","unstructured":"Yi, J.-H., Park, S.-W., Brooks, N., Lang, B. T. & Vemuganti, R. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms. Brain Res. 1244, 164\u2013172. https:\/\/doi.org\/10.1016\/j.brainres.2008.09.074 (2008).","journal-title":"Brain Res."},{"key":"68992_CR77","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.intimp.2018.01.023","volume":"56","author":"Q Wen","year":"2018","unstructured":"Wen, Q. et al. Chrysophanol demonstrates anti-inflammatory properties in LPS-primed RAW 264.7 macrophages through activating PPAR-\u03b3. Int. Immunopharmacol. 56, 90\u201397. https:\/\/doi.org\/10.1016\/j.intimp.2018.01.023 (2018).","journal-title":"Int. Immunopharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68992-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68992-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68992-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T07:07:52Z","timestamp":1723100872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68992-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["68992"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-68992-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"8 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18390"}}